- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
A
A
Agilent Technologies Inc
124.40
0.20+0.16%Pre Market: 124.80 +0.40 +0.32%08:47 02/25 EST
OPEN/PREV CLOSE124.51/124.20
TODAY RANGE123.13-125.83
VOL83.53K
MARKET CAP35.19B
52 WEEK RANGE95.86-159.98
AVG VOL (3M)2.07M
% TURNOVER0.97%
TURNOVER--
P/E (TTM)27.21
% RANGE2.16%
EPS(TTM)4.572
P/E(FORWARD)23.14
P/B5.22
BVPS23.82
DIVIDEND1.020
P/S5.07
BETA--
DIV YIELD0.82%
FREE FLOAT MKT CAP35.12B
SHARES OUTSTANDING282.84M
NEXT EARNINGS02/24-03/02
FREE FLOAT282.30M
LOT SIZE1
EX-DATE03/31/2026
News
Press Releases
Financial Reports
Profile
Simply Wall St·18h ago
Assessing Agilent Technologies (A) Valuation As Earnings Approach And New FDA Diagnostic Approval Draws Interest
Seeking Alpha·21h ago
Lithium Miners News For The Month Of February 2026
Simply Wall St·1d ago
FDA Approval Deepens Agilent Role In KEYTRUDA Ovarian Cancer Testing
Seeking Alpha·3d ago
Earnings week ahead: NVDA, CRM, HD, BIDU, LOW, DELL, SNOW, AMC, ZM, and more
NASDAQ·4d ago
Friday Sector Laggards: Healthcare, Energy
Seeking Alpha·6d ago
Tracking Al Gore's Generation Investment Management Portfolio - Q4 2025 Update
Dow Jones·02/17 14:43
SovEcon Raises Russian Wheat Forecast -- Market Talk
Simply Wall St·02/16 22:13
Agilent Technologies (A) Valuation Check After FDA Expansion Of Keytruda Companion Diagnostic
Simply Wall St·02/14 13:35
The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News
Simply Wall St·02/13 10:22
FDA Ovarian Cancer Nod Puts Focus On Agilent Valuation And Momentum
NASDAQ·02/12 17:31
Daily Dividend Report: AME,A,GLW,ROK,CSCO
Seeking Alpha·02/12 03:55
Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q4 2025 Update
TipRanks·02/12 02:05
Agilent gets FDA approval for PD-L1 IHC 22C3 pharmDx
Same Industry
Name/Symbol
Change%
Price